Login to Your Account



ImClone's Erbitux Receives Long-Awaited FDA Approval

By Kim Coghill


Friday, February 13, 2004
Samuel Waksal's dream of winning FDA approval for his cancer drug Erbitux became reality Thursday, but neither Waksal nor his friend decorating expert Martha Stewart will likely be at the party celebrating the pending launch of the biologic developed by ImClone Systems Inc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription